Teligene

China
Ning’er, Yunnan, China, 215123

Company profile

Teligene company profile

Teligene was established in 2011. It is a high-tech pharmaceutical research and development company focusing on the research and development and industrialization of small molecule innovative drugs. The company's senior technical management team is experienced and familiar with cutting-edge drug development technologies and development trends at home and abroad. The company mainly aims to research and develop hot spots and develop trends of new international small molecule targeted anti-tumor drugs, and designs, screens, optimizes and develops original small molecule targeted anti-tumor drugs with independent intellectual property rights.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2011-01-01, Year

Headquarters

Postal code
215123
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
2
Total equity funding
$92.9M
Last funding
Series C / $92.9M / 2021-02-24
Last equity funding
Series C / $92.9M
Investors
5
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Xiaoyang Xia

Lead investors

ShenZhen GTJA Investment Group

Investors

CCB CapitalIDG CapitalLoyal Valley CapitalShenzhen Capital GroupShenZhen GTJA Investment Group